Antibacterials in the pipeline and perspectives for the near future
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference51 articles.
1. Insights into newer antimicrobial agents against Gram-negative bacteria;Taneja;Microbiol Insights,2016
2. Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI);Solomkin;Clin Infect Dis,2015
3. Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections;Kauf;BMC Infect Dis,2017
4. Diazabicyclooctanes (DBOs): a potent new class of non-beta lactam beta lactamase inhibitors;Coleman;Curr Opin Microbiol,2011
5. In vivo efficacy of meropenem with a novel non-β-Lactam- β-lactamase inhibitor, nacubactam, against Gram-negative organisms exhibiting various resistance mechanisms in a murine complicated urinary tract infection model;Monogue;Antimicrob Agents Chemother,2018
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chatting with artificial intelligence to combat antibiotic resistance: Opportunities and challenges;Current Research in Biotechnology;2024
2. Full Profiling of GE81112A, an Underexplored Tetrapeptide Antibiotic with Activity against Gram-Negative Pathogens;Microbiology Spectrum;2023-06-15
3. A bifunctional electrochemical sensor for simultaneous determination of electroactive and non-electroactive analytes: A universal yet very effective platform serving therapeutic drug monitoring;Biosensors and Bioelectronics;2022-07
4. Biosynthetic versatility of marine-derived fungi on the delivery of novel antibacterial agents against priority pathogens;Biomedicine & Pharmacotherapy;2021-08
5. Medicinal Chemistry of β‐Lactam Antibiotics;Burger's Medicinal Chemistry and Drug Discovery;2021-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3